. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neurosci Lett. 1998 Oct 9;255(1):21-4. PubMed.


Please login to recommend the paper.


  1. If replicated, these data suggests that somatostatin may be used in AD treatment.

Make a Comment

To make a comment you must login or register.